We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8795:TSET&D Holdings, Inc. Analysis

Data as of 2026-06-13 - not real-time

¥4,712.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

T&D Holdings is trading at ¥4,712, comfortably above its 20‑day (¥4,273), 50‑day (¥4,074) and 200‑day (¥3,792) simple moving averages, confirming a strong bullish trend. The Relative Strength Index sits at 74, signaling an overbought condition, while the MACD histogram remains positive (+¥53) and the MACD line exceeds its signal line, reinforcing bullish momentum. However, the discounted cash‑flow fair value of ¥2,387 suggests the market price is roughly double intrinsic value, flagging a significant overvaluation. The stock benefits from an attractive dividend yield of 3.48% with a payout ratio of 46.5%, supported by robust operating cash flow of ¥150 bn and free cash flow of ¥46.9 bn.
Fundamentally, revenue grew 10.2% YoY and operating margins are unusually high at 63%, while ROE is modest at 9.6%. The company’s beta of 0.58 and 30‑day volatility of 33.6% indicate moderate market sensitivity but heightened price swings. The “Extreme Greed” sentiment index (89.86) reflects strong investor enthusiasm, yet the downside upside metric shows only a 12% upside potential. Overall, the blend of strong cash generation, solid dividend, and overbought technicals creates a nuanced picture for investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI overbought at 74
  • Price near resistance level of ¥4,981
  • Strong dividend yield providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • 10% revenue growth and 63% operating margin
  • Bullish MACD and price above all major SMAs
  • Sustainable dividend payout supporting total return

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Stable cash flows and moderate leverage
  • Demographic tailwinds for life‑insurance in Japan
  • Potential valuation correction given DCF gap

Key Metrics & Analysis

Financial Health

Revenue Growth10.20%
Profit Margin4.76%
P/E Ratio16.9
ROE9.57%
ROA1.59%
Debt/Equity14.34
P/B Ratio1.4
Op. Cash Flow¥150.2B
Free Cash Flow¥46.9B
Industry P/E16.8

Technical Analysis

TrendBullish
RSI74.0
Support¥3,900.00
Resistance¥4,981.00
MA 20¥4,273.15
MA 50¥4,074.50
MA 200¥3,792.14
MACDBullish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair Value¥2,386.94
Target Price¥4,717.78
Upside/Downside0.12%
GradeOvervalued
TypeValue
Dividend Yield3.48%

Risk Assessment

Beta0.58
Volatility33.57%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.